Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT03919994
Eligibility Criteria:
Inclusion Criteria:
* Must be able to speak, read and understand English
* Diagnosis of schizophrenia as defined by the treating clinician
* Newly initiating treatment with 1 of 4 atypical Long Acting Injectables (LAIs): Abilify Maintena, Aristada, Invega Sustenna, or Risperdal Consta)
* Additional criteria may apply
Exclusion Criteria:
* Currently participating or planning to participate in an interventional clinical study, or has completed participation in an interventional clinical study within 30 days before enrollment
* In the opinion of the investigator, is currently an imminent danger to himself/herself. \[Note: A prior history of suicidal ideation or suicidal attempt is not exclusionary.\]
* Additional criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03919994
Study Brief:
Protocol Section:
NCT03919994